In light of recent decisions by the European Medicines Agency (EMA) there is likely to be a call for an increased level of data sharing including from other regulatory agencies. The objectives of this meeting were to provide a forum for discussion of the rationales and implications of this paradigm change and to begin to consider potential solutions.
For more information please see links below.
2013-05-17 P-C MRCT GHI Meeting Proceedings